The ShiftShapers Podcast
Change either paralyzes or energizes - the choice is yours. Hear from businesses and entrepreneurs who have become energized and who have profited by shaping the shifts in their markets and practices. Become a SHIFTSHAPERS INSIDER and get our latest download, advance notice of all podcasts, podcast summaries, and special INSIDER-ONLY content. INSIDER SIGN UP
The ShiftShapers Podcast
Ep #141: Post-election Healthcare Review – With Jessica Waltman – Part 2
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
On part two of this special, post-election edition of the ShiftShapers podcast, we discuss policy ideas that may be seeing a resurgence based on the election outcome and whether these ideas can really bring down costs in the healthcare marketplace.
Jessica Waltman, Principal at Forward Health Consulting and our resident expert on all things legislative and regulatory joins us for part 2 of our look at healthcare in this post-election period.
We discuss the theory being floated that an individual healthcare marketplace will control costs better than the employer-based system currently in place. We are also hearing a great deal about selling across state lines. Jessica walks us through a practical example of how that theory actually performed in the Georgia market. And finally, we touch on the third rail in healthcare: dealing with hyperinflated and runaway costs on the supply side.
We also explore whether to expect any initiatives that address one of the largest cost drivers – prescription drugs. We wrap up with a serious discussion of the timing – and the time – it will take to unravel PPACA and make meaningful serious reforms, as well as the possible perils of acting too quickly.
What You’ll Learn From this Episode:
- Policy ideas being proposed from conservative economists on how best to structure the health care system.
- A practical example of whether purchasing healthcare across state lines encourages competition and brings down the price.
- Why rural markets are inherently difficult to serve by healthcare providers.
- What President-elect Trump has hinted about controlling drug prices.
- The strategies in place to address the main cost drivers on the supply side.
- Whether value-based pricing is the first step in reigning in runaway facilities costs.
- What advisors should do in preparation for the upcoming enrollment period.
Welcome back to part two of our Shift Shapers post-election wrap-up with Jessica Waltman.
SPEAKER_00Either paralyze it or energize it. The choice is yours. You're listening to the Shift Shapers Podcast. You're about to learn firsthand from businesses and entrepreneurs who have successfully shaped the chips and the industries. Get ready to become the change that you want to see. Here's your host and chief transformation strategist, David Stoltzman.
DavidThis episode of the Shift Shapers Podcast is brought to you by Captivated Health, a captive insurance arrangement designed specifically for educational institutions. If you have clients in that vertical, you know the healthcare deck has been stacked against them. Today, Captivated Health offers the stability, control, and savings they've been waiting for. For more information, go to www.captivatedhealth.com or click on the company logo on the Shift Shapers website. Let's talk about a couple of other old ideas that seem to kind of have a half-life like plutonium. And the first is an undercurrent that has been around in Republican circles for a long, long time. And that's this notion that we'd be better off if we moved away from employer-based health insurance to a more individually based or a fully individually based marketplace. Is that idea still floating out there? Do you think it's going to gain any traction? How might it impact the discussion?
SPEAKER_02Well, absolutely. It's it's part of the discussion. Speaker Ryan has been a long proponent of that. It's a component of the price plan. I mean, really, if you look at any conservative, you know, come from a conservative academic perspective, I would say that is a component of it. I actually read an interesting piece, kind of arguing in that that way this morning in the New York Times, but it was an opinion section, and the column was called Upshot, and it was from a University of Michigan economist named Nicholas Bagley, and then another guy, Austin Frack, who who writes this blog called The Incidental Economist. And their argument was for more of a individual market-based, individual tax credit-based system, based on the whole theory that you know what works for one person doesn't work for all, and that we cannot replace health reform with a one-size-fits-all approach. And they they drew some very interesting analogies, and they were really arguing, I think, from a very academic perspective, that you know, involving individual choices and the employer-based system, because it kind of takes the individual out of the purchasing equation, is what's the big problem. But I think that they're missing, all of these people are missing really a key component because they come at it from a very academic perspective. And I mean, this article actually even really argued in favor of the Cadillac tax, which again, a lot of health economists from a very ivory tower perspective think will work. And those that that favor individual tax credits, even if they may not like the Cadillac tax per se, you have to be very careful because they talk about either eliminating the exclusion or capping the exclusion. And for employer plans, it's not just the disincentive to offer coverage that comes with that, but in a cap with of an exclusion, that creates all the complications the Cadillac tax would cause too, because you would have to track it. You know, how would you know? How would you figure out what the value of your plan was to see if you met the exclusion? And how would you tell the IRS that you met the cap or not? You know, it's it's employer reporting times a million more, you know, more complicated. And what falls under those caps? I mean, all those concerns that we had, you know, does an HSA fall under the cap? You know, is that hit with the exclusion? You know, how does that factor in with a tax credit? All of these questions come up again and become very complicated, both for individuals and employers. But anyway, I'm going down onto a tangent, but I think that the point that those that favor the employer-based system need to make is yes, you're hitting on one P piece that individual employees do not necessarily feel very connected to their purchasing decisions, and they're not necessarily making the best decisions relative to their medical care because price is taking it away from them. But putting it in an individual market-based system, I don't know that that's really the answer to that either. I think what we might want to focus on more is price transparency and then also the value that a large purchasing pool and a large group market and like large groups of people together can do for innovative things to bring down health because individual actors alone, it's just so much harder to apply innovations that might reduce cost to the individual market and an individual risk pool. But large employers are doing fabulous things to bring down costs in their plan and really investigating it. And we have such laboratories of cost containment going on in individual companies now. Why would we want to throw that away? Plus, I personally just think no one wants to buy individual coverage. It's it's just they like it. People like getting it through their employer because it's cheaper and easier for them. And I don't think we can discount what the American people like. And, you know, making things more difficult for them isn't really a winning political strategy.
DavidWell, I think we learned that in this election for sure. But here's the second of the two things that I want to talk about. That's kind of an old line idea. And this one in particular leaves a lot of people scratching their heads. And that's this notion of selling across state lines. How much of that are we going to see? Does that even make sense as a strategy? Is it even practical?
SPEAKER_02Right. No, that is one that, you know, everything old is new again that just keeps coming back around. And lots of people like it. And on the campaign trail, I mean, I remember seeing one interview with President elect Trump, and he was asked about his health policy, and he said, Well, coverage across state lines. And the interviewer said, Well, you know, what else? And he said, What else is there? You know, that's that's it. And I think, you know, that was early on in the campaign. His health policy strategy hadn't really been fleshed out, and that was his you know, message point of the day, and he made it. But I'm not going to take it terribly literally, but you know, it's definitely coming back, and it's definitely something that has, you know, been an idea of people like Tom Price and others. I do think that Tom Price at HHS, though, might have some interesting perspective to put on that. You know, Georgia isn't one of a number of states that passed state-level legislation to allow purchasing across state lines and to allow insurers to come in and help the Georgia marketplace because there are certainly areas of Georgia, rural counties where competition is really poor and it's very hard to negotiate with providers. There's some really expensive parts of Georgia to buy coverage, and it's not Atlanta, it's rural counties. And they thought this will be it, it will help us. And you know how many insurers have come in to serve those markets and want to do it?
DavidI'll bet it's not a big number. Yeah, zero.
SPEAKER_02Yeah, zero, zero. You know, other states have done it too. So it's kind of like if you build it, will they come? And I think that the practical experience in the states, or no, it hasn't. And if you talk to state insurance commissioners and others, you know, they may say, you know what, this isn't really the best idea. Like this is not exactly what we wanted. And ACA even contained a nod to coverage across state lines with the multi-state plans. And then even with the exchanges. I mean, they were you were supposed to be able to do exchanges across state lines and have groups of exchanges. And what they found out was it just doesn't work that way. It's not practical, it's not cost effective. You'd think that sharing resources and blurring those lines would work, and it just really doesn't. There's just so many costs and geographical concerns and other practical matters that just get in the way. It's just not a solid business proposition once you really get down into the weeds. So I think that Tom Price certainly knows the impact it's had in Georgia. It was kind of a big deal there. And they were, it was very highly touted and it just didn't work. And I think that, you know, as things play out, maybe we might have something that sounds like coverage across state lines or allows for the possibility. But just because something a possibility is allowed for doesn't mean that it's going to be the piece of the puzzle. You know, it doesn't really mean it's going to be the silver bullet.
DavidSo we've got about another 10 minutes left in our conversation. And you touched on something earlier that I'd like to explore. You said something that I say all the time that health insurance is expensive because health care is expensive. ACA, other than arguably some tacit nod or tilt of the hat to ACOs, didn't do an awful lot on the supply side. It was more focused on the demand side. Are there any initiatives? Is anybody talking about what seems to have become the third rail of healthcare coverage in the United States, which is the cost problem and then its twin sister, the transparency side?
SPEAKER_02Somewhat. So as I mentioned, there's a coalition of business groups, insurers, you know, agents and brokers, other interested parties that just were reaching out to the Trump administration today to urge them to move in that direction. Similarly, I saw that in his man of the year interview, President-elect Trump went after drug prices, which a lot of people thought, oh, you know, this is something that a Trump administration might not do. And that was certainly more of a Clinton talking point on the campaign trail. You know, he just said, hey, I yeah, they're too high. There's something going on there. And it wasn't very specific, but he said, you know, we got to look at these costs and what's going on here. You know, where do we go with that? It's questionable, but you know, he's not wrong. It's certainly one of the key drivers of premiums right now, and there's a lot of reasons why that is. And a lot of people have a lot of different ideas about what to do. You know, he even talked about controlling drug prices in the interview, apparently, but I don't know that that was a literal reference to price controls, as it was more let's look at this. Is there any practical, you know, I hope that it's more like let's look at this. Are there practical solutions to make these less expensive for everyone, but yet not limit the drug innovation that goes on in this country that really helps, you know, the rest of the world medically and us as well. So hopefully we'll we'll go down that road. But I think that it's something that as this moves forward, stakeholders with great connection to the actual marketplace and not you know, kind of academics, really need to can to hammer home. And this is a really good opportunity to really focus in on the cost of medical care. You know, particularly if we do a deliberative, longer process to replace what we have now thoughtfully. There could be a great opportunity to move in that direction. But we have to be prepared with policy ideas to fill in, because as we just discussed, the policy ideas that are being suggested now are old school ideas that don't necessarily get at that at all.
DavidAnd now a word from our sponsor. Captivated health is a single source solution for your clients and prospects who are in the education vertical. The founders of Captivated Health have nearly 20 years' experience working with educational institutions, and over that time, they've developed a keen understanding of the unique problems these clients experience. Frustrated by a lack of control, the unpredictability of ever increasing health care costs, and the pressures and regulations of the Affordable Care Act, these groups have been adrift in the fully insured commercial marketplace until now. Captivated Health has built a program that solves those problems, and it does so with virtually no disruption to faculty and staff while saving clients millions of dollars. We wanted you to be among the first to know that Captivated Health is building a national distribution partner network so you can bring this cutting-edge solution to the educational clients you advise. To learn more about the Captivated Health Solution, go to their website at www.captivatedhealth.com or click on their logo on the Shift Shapers website. And now back to our interview. And the vast majority of spend comes on the facility side, and those numbers are just insanely crazy and completely and totally irrational. Do you believe that value-based or metric-based pricing is the first step toward reining that in, or does something more drastic need to happen?
SPEAKER_02Well, I think it's definitely a step in the right direction, but I honestly think we really need to take a good hard look at the whole, you know, all of that and why. Because it is representing such a huge amount of the costs that we have right now. And there's, you know, things that you can do and say, hey, let's look and see why is an MRI, you know, one price one place, one at another. We add in transparency, we add in value-based components to the plan design. You know, we we do that, but that doesn't get into the underlying problem of why do we have so many facilities that need to have these costs, or why are they charging so much, or what you know, what is underlying all that? And it it's pretty complicated. And I think that we haven't spent a ton of time over the last you know, six years in particular, really analyzing and coming up with thoughtful solutions. A lot of people have been saying this, what we have now has to go. And so now we have this really great time, and hopefully we'll take it to look on a bipartisan basis and say, okay, what are the problems here? Let's look at all the sectors. And are there small changes and large institutional changes we can make to lower the cost for everyone? Because otherwise we're just spinning our wheels and we can make changes to the financing mechanism, like you said, but if the overall cost never goes down, it's not going to be helpful. And that would help not only the private insurance market, but also that's what's needed to sustain Medicare, Medicaid, and other private public-private programs.
DavidWe've got just a few minutes left, so it's not fair to touch on what is the real third rail of reform. But that would be the thing that's starting to melt liberals down is Medicare privatization and Medicaid cutbacks or changes in the scheme so that it's more block granted. Are those going to get caught up in the overall general healthcare reform discussion, or do you think they'll be taken up separately?
SPEAKER_02Well, you know, that's a great question because you could argue very forcefully that, you know, just as an example, the Medicaid expansion expanded a system and brought all these new people into the coverage system on a system, you know, that is unsustainable. And it's just antiquated even in terms of its technology, and you know, that this has cost us a lot of money. We shouldn't have just expanded on a broken system. We should have fixed first and then, you know, seen what we could do. I mean, it's particularly with Medicaid, it's really when you talk about changing the structure and what might happen to the expansion. And so that might be one of the really good things about and maybe a positive argument and maybe something that could bring in, bring the sides together relative to Medicaid, is if you had criteria for waivers that would really encourage the states to take that money and make the specific fixes that they each need to get their systems under control because there's a lot of wasted costs and problems. I mean, Medicaid's infrastructure has a lot of issues in many states. So, you know, maybe they're yes, Medicare and private premium support. I think that really when we talk about health reform replacement and changes, that would be adding in a whole other element. And while that may be very important and interesting to Speaker Ryan and others, and maybe something you want to look at at the long term, I think that that might be something that, you know, it seems like they're talking about doing separately. And perhaps that will be the most effective strategy because I mean, I don't know that you really need to add anything to the pile that needs to be dealt with with health reform.
DavidAnything else in the couple of minutes that we have left, is there anything else that you see coming down in the near term that advisors and their clients need to be acutely aware of?
SPEAKER_02Well, I think one of the most important things is to not panic and just you recognize that requirements are still there and that in the very short term, you know, the focus really needs to be on helping clients, you know, stay the course. It's unlikely that employer reporting is gonna change for this year. You know, that the these are things that maybe for next year, yes, but you you still need to be, you know, the new summary of benefits and coverage is still coming out in April. You know, it's possible that we're just gonna throw those documents away, but you know, you still need to be preparing for it. If you have an April 1 renewal, you know, they they need to be giving those out for their upcoming enrollment. I mean, it's unlikely that the Trump administration and the new Congress are going to get those things, you know, just thrown out the window right away. So I think that for advisors and then their employer clients, you know, just really not to panic, but then also to keep your ear to the ground and just be really in tune to what changes might be coming. But recognizing that this is not, you know, this is a law that was passed now coming up almost seven years ago, and we are still in the implementation phase of a lot of it. And now we're talking about undoing it. You know, it rum was not built in a day, and Rome was not dismantled in a day.
DavidSo well, uh, from an old movie, fasten your seat belts, it's going to be a bumpy ride, but it should be fun. Jessica Waltman, principal at Forward Health Consulting. Jessica, as always, thank you for your insights and happy new year.
SPEAKER_02Happy New Year to you too.
DavidThe Shift Shapers podcast is a production of Strategic Vision Publishing and David Saltzman. This podcast may not be reproduced in any form, in whole or in part, without the express written permission of the producers. All rights reserved.